NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.00185.c: Acyl-CoA dehydrogenase

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: diffraction
center reference id: MysmA.00185.c
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.00185.c.A1.GE28579 Full length( MysmA.00185.c ) 1 389 GE28579
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.00185.c.A1.PS00541 Full length( MysmA.00185.c ) 1 389

External Resources

Resource Reference ID
OrthoMCL: OG5_129653
PATRIC ID: fig|246196.19.peg.1802
RefSeq: YP_886192.1
UniProt: A0QTF4

Enzyme & Pathway Information

Pathway Pathway ID EC Number
pyruvate fermentation to butanoate CENTFERM-PWY 1.3.8.1
L-glutamate degradation VII (to butanoate) GLUDEG-II-PWY 1.3.8.1
L-glutamate degradation V (via hydroxyglutarate) P162-PWY 1.3.8.1
L-lysine fermentation to acetate and butanoate P163-PWY 1.3.8.1
gallate degradation III (anaerobic) P3-PWY 1.3.8.1
beta-alanine biosynthesis II PWY-3941 1.3.8.1
superpathway of coenzyme A biosynthesis II (plants) PWY-4221 1.3.8.1
4-aminobutanoate degradation V PWY-5022 1.3.8.1
superpathway of L-lysine degradation PWY-5327 1.3.8.1
acetyl-CoA fermentation to butanoate II PWY-5676 1.3.8.1
succinate fermentation to butanoate PWY-5677 1.3.8.1
pyruvate fermentation to butanol I PWY-6583 1.3.8.1
superpathway of Clostridium acetobutylicum acidogenic fermentation PWY-6590 1.3.8.1
superpathway of Clostridium acetobutylicum solventogenic fermentation PWY-6594 1.3.8.1
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation PWY-6604 1.3.8.1
glycerol degradation to butanol PWY-7003 1.3.8.1

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MAAWGGNPSF DLFQLPEEHQ ELRAAIRALA EKEIAPHAAD VDENARFPQE ALDALNASGF NAVHVPEEYG GQGADSVAAC IVIEEVARVD ASASLIPAVN KLGTMGLILR GSDELKKQVL PQLASGAAMA SYALSEREAG SDAASMRTRA RADGDDWVLN GTKCWITNGG KSSWYTVMAV TDPDKGANGI SAFMVHQDDE GFSVGPKERK LGIKGSPTTE LYFENCRIPG DRIIGEPGTG FKTALATLDH TRPTIGAQAV GIAQGALDAA IAYTKDRKQF GTSISDFQAV QFMLADMAMK VESARLMVYH AAARAERGEK NLGFISAASK CLASDIAMEV TTDAVQLFGG AGYTQDFPVE RMMRDAKITQ IYEGTNQIQR VVMSRALLR

NT Sequence
ATGGCTGCAT GGGGCGGCAA TCCGTCTTTC GATCTGTTCC AGTTGCCCGA GGAGCATCAG GAGTTGCGGG CGGCGATCCG TGCGCTGGCT GAGAAGGAGA TCGCGCCGCA CGCTGCCGAT GTGGATGAGA ATGCGCGGTT TCCGCAGGAG GCGCTCGATG CGTTGAATGC TTCGGGGTTC AACGCGGTGC ACGTGCCTGA GGAGTACGGC GGTCAGGGCG CGGATTCGGT CGCGGCGTGC ATCGTGATCG AGGAGGTCGC GCGGGTGGAT GCCTCGGCGT CGTTGATCCC GGCGGTCAAC AAGCTGGGCA CGATGGGGTT GATCCTGCGT GGTTCGGATG AGTTGAAGAA GCAGGTGTTG CCGCAGTTGG CCTCGGGTGC GGCGATGGCG TCGTATGCGT TGTCCGAGCG TGAGGCCGGC AGTGATGCGG CGAGTATGCG CACGCGGGCC AGGGCCGATG GGGATGACTG GGTTCTCAAC GGCACCAAGT GCTGGATCAC CAATGGTGGT AAGTCGTCGT GGTACACGGT GATGGCGGTG ACCGATCCGG ACAAGGGTGC CAACGGGATT TCGGCGTTCA TGGTGCACCA GGACGACGAG GGGTTCAGCG TCGGTCCCAA GGAGCGCAAG CTGGGCATCA AGGGGTCGCC GACCACGGAG TTGTATTTCG AGAACTGTCG GATTCCCGGG GATCGGATCA TCGGTGAGCC GGGTACGGGG TTCAAGACGG CGTTGGCGAC GTTGGATCAC ACGCGCCCGA CGATCGGGGC GCAGGCGGTG GGGATCGCCC AGGGTGCGTT GGATGCGGCG ATCGCCTACA CCAAGGACCG CAAGCAGTTC GGTACGAGCA TCAGTGATTT TCAGGCTGTG CAGTTCATGT TGGCCGATAT GGCGATGAAG GTCGAGTCGG CGCGGTTGAT GGTGTATCAC GCCGCGGCGC GTGCTGAGCG TGGTGAGAAG AACCTGGGGT TCATCTCGGC GGCCAGTAAG TGTCTGGCGT CGGATATCGC CATGGAGGTC ACCACCGATG CGGTGCAGTT GTTCGGCGGT GCGGGTTATA CGCAGGACTT CCCGGTGGAG CGGATGATGC GTGATGCCAA GATCACCCAG ATCTATGAGG GCACCAACCA GATCCAGCGC GTGGTCATGA GCCGCGCCCT GCTGCGC

© 2020 Seattle Children's Research Institute. All rights reserved.